75
64
Growth Score 75 in past quarter
-10 pts
Heat Score 64 in past quarter
34 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1108404
ReGEN Biomedical develops tools and services for regenerative medicine, 3D cell culture, and tissue engineering.
- Marleen Nuenen: CEO
- Maurice Hermans: CFO
About the Company
ReGEN Biomedical develops biomedical technologies that support regenerative medicine, cell biology, and tissue engineering. The company provides research services and custom development for in vitro models, including 3D cell culture and biomaterial scaffolds. Offerings include assay design, protocol optimization, and small-scale fabrication to
evaluate cell behavior, matrix interactions, and implant concepts. Solutions address drug discovery, preclinical testing, and translational research by increasing the relevance and reproducibility of laboratory models. Collaboration options include contract research projects and technology transfer to client laboratories.